Search Results

Paragonix Technologies, Inc. announces the full commercial launch of its next-generation transport device, the BAROguard™ Donor Lung Preservation System.

Paragonix Technologies, a leader in organ transplant technology, proudly announces the PancreasPak™ Organ Preservation System, the first FDA-cleared device designed to protect and monitor donor pancreases during transportation.

Paragonix Technologies, Inc., a pioneer in organ transplant technologies and services, presented impactful clinical data on the use of its Advanced Organ Preservation system, LUNGguard®, in the largest real-world multi-center study presented at the 44th ISHLT Annual Meeting and Scientific Sessions – one of the largest international conferences focused on advanced treatment for end-stage heart and lung disease

Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the launch of a comprehensive network of donor organ procurement, preservation, and transportation services.

Paragonix Technologies, Inc., a pioneer in organ transplant products and services, is honored to announce the forthcoming release of new clinical data supporting the use of controlled hypothermic preservation and clinical services.

Paragonix Technologies is proud to publicly announce the recurrent success of a new, innovative strategy recently developed to minimize the complexities and logistics of placing high-risk donor livers.